Prevalence, awareness, treatment and control of hypertension in Malaysia: A national study of 16,440 subjects

Public Health

Volumn 122, Issue 1, 2008, Pages 11-18

  Rampal, L ^a   Rampal, S ^b   Azhar, M Z ^c   Rahman, A R ^d  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c Putra Malaysia University   (Malaysia)

^d CYBERJAYA UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Awareness; Control; Epidemiology; Hypertension; Malaysia; Prevalence; Treatment

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BLOOD; BODY CONDITION; DISEASE CONTROL; DISEASE PREVALENCE; DISEASE TREATMENT; HYPERTENSION; LOGISTICS; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS;

ADOLESCENT; ADULT; AGING; ARTICLE; AWARENESS; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; CLUSTER ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DIASTOLIC BLOOD PRESSURE; EDUCATION; FAMILY HISTORY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NURSE PRACTITIONER; PREVALENCE; PUBLIC HEALTH; RISK ASSESSMENT; SELF REPORT; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; MALAYSIA; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION;

ASIA; EURASIA; MALAYSIA; SOUTHEAST ASIA;

EID: 37049026915     PISSN: 00333506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.puhe.2007.05.008     Document Type: Article

References (28)

1. Murray C.J., and Lopez A.D. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349 (1997) 1269-1276
2. World Health Organization. World health report. Mental health: new understanding, new hope (2001), WHO, Geneva p. 144-9
3. Wolf-Maier K., Cooper R.S., Banegas J.R., Giampaoli S., Hense H.W., Joffres M., et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289 (2003) 2363-2369
4. He J., and Whelton P.K. Epidemiology and prevention of hypertension. Med Clin North Am 81 (1997) 1077-1097
5. Whelton P.K. Epidemiology of hypertension. Lancet 344 (1994) 101-106
6. Ezzati M., Lopez A.D., Rodgers A., Vander H.S., and Murray C.J. Selected major risk factors and global and regional burden of disease. Lancet 360 (2002) 1347-1360
7. Whitworth J.A. 2003 World Health Organization/International Society of Hypertension statement on management of hypertension: WHO, ISH Writing Group. J Hypertens 21 (2003) 1983-1992
8. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., and He J. Global burden of hypertension: analysis of worldwide data. Lancet 365 (2005) 217-223
9. World Health Organization. World health report 2002 Reducing risks, promoting healthy life (2002), WHO, Geneva
10. Ueshima H., Zhang H., and Choudhury S.R. Epidemiology of hypertension in China and Japan. J Hum Hypertens 14 (2000) 765-769
11. Singh R.B., Suh I.L., Singh V.P., et al. Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention. J Hum Hypertens 14 (2000) 749-763
12. Kannel W.B. Blood pressure as a cardiovascular risk factor. JAMA 275 (1996) 1571-1576
13. Levy D., Larson M.G., Vasan R.S., Kannel W.B., and Ho K.K.L. The progression from hypertension to congestive heart failure. JAMA 275 (1996) 1557-1562
14. Klag M.J., Whelton P.K., Randall B.L., Neaton J.D., Brancati F.L., Ford C.E., et al. Blood pressure and end-stage renal disease in men. N Engl J Med 334 (1996) 13-18
15. MacMahon S., Peto R., Cutler J., Collins R., Sorlie E., Neaton J., et al. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335 (1990) 765-774
16. StataCorp. Stata statistical software: release 9.2 (2005), Stata Corporation, Texas
17. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension 2003;1206-52.
18. Anderson K.M., Wilson P.W.F., Odell P.M., and Kannel W.B. An updated coronary risk profile. A statement for the health professionals. Circulation 83 (1991) 356-362
19. Rampal L., Sanjay R., Azhar M.Z., Shafie O., Ramlee R., Sirajoon N.A.G., et al. A population based national study on the prevalence of smoking among Malaysians aged 15 years and above. In: Varma A.K. (Ed). Tobacco counters health vol. 4 (2006), Northern Book Centre, New Delhi 113-121
20. Ministry of Health, Malaysia. Report of the second national health and morbidity survey conference proceedings. 1997. p. 71-80.
21. Burt V.L., Curtler J.A., Higgins M., Horan M.J., Labarthe D., Whelton P., et al. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population. Hypertension 26 (1995) 60-69
22. Ashraf M.S., and Vongpatanasin W. Estrogen and hypertension. Curr Hypertens Res 8 (2006) 368-376
23. Rasool AHG, Rahman ARA, Ismail R, Hatim S, Abdullah ARW, Singh R, et al. Ethnic differences in response to non-selective beta blockade among racial groups in Malaysia. Int J Clin Pharmacol Ther 2000;260-9.
24. Rehman A.R., Rasool A.H.G., and Rahman A.R. Influence of angiotensin 11 type 1 receptor gene A1166C polymorphism on BP and aortic pulse wave velocity among Malays. Ann Hum Genet 71 (2007) 86-95
25. Wang Z., Wu Y., Zhao L., Yang J., and Zhou B. Cooperative research group of the study on trends of cardiovascular diseases in China and preventive strategy for the 21st century. Hypertens Res 27 (2004) 703-709
26. The sixth report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 1997;157:2413-46.
27. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P., and He J. Global burden of hypertension: analysis of worldwide data. Lancet 15 (2005) 217-223
28. Erdine S., and Aran S.N. Current status of hypertension control around the world. Clin Exp Hypertens 26 (2004) 731-738